Academic literature on the topic 'Maculopapular exanthema'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Maculopapular exanthema.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Maculopapular exanthema"

1

Fernández, Tahia D., Gabriela Canto, and Miguel Blanca. "Molecular mechanisms of maculopapular exanthema." Current Opinion in Infectious Diseases 22, no. 3 (June 2009): 272–78. http://dx.doi.org/10.1097/qco.0b013e3283298e62.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pilar Hernández, Alfonso, Mahave Idoia González, Oribe Irene Vidal, del Pozo Gil Mª Dolores, Díaz Mónica Venturini, and Labairu Teófilo Lobera. "Maculopapular delayed exanthema due to ranitidine." Annals of Dermatological Research 4, no. 1 (December 23, 2020): 014–16. http://dx.doi.org/10.29328/journal.adr.1001012.

Full text
Abstract:
Ranitidine is a widely used drug in Europe and its intake is usually well tolerated. Hypersensitivity reactions due to ranitidine are uncommon. The immediate mild reactions type are the most prevalent. In some special cases a delayed type reaction such as contact dermatitis or severe reactions with systemic involvement have been reported. In the present paper, a case report of a 78-year old patient who experienced a maculopapular eruption after 7 days of oral treatment with ranitidine is described. Patch tests were performed twice with ranitidine with positive results confirming the diagnosis. In order to discard a double sensitization and a possible cross-reactivity phenomenon, patch test was performed once with famotidine, with a negative result. This is the first maculopapular exanthema reported as type IV hypersensitivity reaction to ranitidine confirmed by patch testing. Moreover, there are only two reported cases showing a double sensitization to ranitidine and to other H2-receptor antagonists by patch testing after a delayed reaction due to ranitidine, the other being H2-receptor antagonists involving cimetidine and nizatidine, not famotidine.
APA, Harvard, Vancouver, ISO, and other styles
3

Borja, J. M., P. A. Galindo, F. Feo, E. Gomez, and A. Lasanta. "Maculopapular exanthema from diacetyl-midecamycin (MOM)." Allergy 53, no. 10 (October 1998): 1004–5. http://dx.doi.org/10.1111/j.1398-9995.1998.tb03805.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Orsini, Marco, Jacqueline Fernandes Nascimento, Antônio Marcos da Silva Catharino, Marcos RG Freitas, and Acary Bullede Oliveira. "Exanthema after lamotrigine use: A clinical case." International Journal of Case Reports and Images 13, no. 1 (June 16, 2022): 20–23. http://dx.doi.org/10.5348/101314z01mo2022cr.

Full text
Abstract:
Introduction: Lamotrigine is a phenyltriazine compound that inhibits sodium and potassium channels in presynaptic neurons. Maculopapular exanthema is a common side effect of Lamotrigine therapy, occurring most frequently during the first eight weeks of treatment in approximately 3–10% of patients. Case Report: A 74-year-old female had started Lamotrigine 50 mg due to emotional lability and depression. About 8–9 weeks after the introduction of the drug she presented a rash with exanthema, maculopapular in appearance. The attending physician suggested discontinuation of the medication and reevaluation. Complete regression of the clinical picture occurred. No severe skin rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis were observed. Conclusion: Lamotrigine is effective for a variety of types of conditions involving neuronal excitability, however, such drug exposes the individual to side reactions ranging from mild skin rashes to even those leading to hospitalization. Measures such as adherence to the manufacturer’s dosing guidelines, titration, and intrinsic characteristics of the individual can minimize this effect.
APA, Harvard, Vancouver, ISO, and other styles
5

Koch, André, Georgi Tchernev, and Uwe Wollina. "Allergic Maculo-Papular Exanthema Due To Terbinafine." Open Access Macedonian Journal of Medical Sciences 5, no. 4 (July 20, 2017): 535–36. http://dx.doi.org/10.3889/oamjms.2017.105.

Full text
Abstract:
We report on a 76-year-old male patient who developed a maculopapular generalised exanthema due to terbinafine. Prick test was negative; patch test revealed a positive reaction after 48 h confirming the delayed-type allergic reaction. Non-pustular exanthema has only rarely been reported for terbinafine.
APA, Harvard, Vancouver, ISO, and other styles
6

Bircher, A. J., and M. Rutishauser. "Oral "desensitization" of maculopapular exanthema from ciprofloxacin." Allergy 52, no. 12 (December 1997): 1246–48. http://dx.doi.org/10.1111/j.1398-9995.1997.tb02534.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Fatkullina, G. R., V. A. Anokhin, and G. R. Khasanova. "Ring-shaped erythema and herpetic infections in children." Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 66, no. 5 (December 9, 2021): 207–12. http://dx.doi.org/10.21508/1027-4065-2021-66-5-207-212.

Full text
Abstract:
Exanthema in children accompanies various diseases. Often, polymorphic elements on the skin occur against the background of infectious diseases. Until the second part of the XXth century, children’s classical infectology described only 6 diseases in children characterized by spotty and maculopapular rash. Now there are more than two dozen exanthemes in children with an “infectious origin”. The article considers 2 clinical cases of a relatively rare annular erythema in patients of 1 year 2 months and 11 months associated with chronic herpetic infections. The article presents photo documents of the dynamics of the skin process and laboratory parameters against the background of antiviral therapy.
APA, Harvard, Vancouver, ISO, and other styles
8

Eber, Elena, Teresa Deinlein, Birger Kränke, and Birgit Sadoghi. "Persisting maculopapular exanthema in a 78‐year‐old woman." JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19, no. 5 (January 25, 2021): 786–89. http://dx.doi.org/10.1111/ddg.14375.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

FERNANDEZ, T., M. TORRES, C. ANTUNEZ, J. CORNEJOGARCIA, M. DELPRADO, G. REQUENA, M. BLANCA, and C. MAYORGA. "Role of Effector Cells In Drug-induced Maculopapular Exanthema." Journal of Allergy and Clinical Immunology 121, no. 2 (February 2008): S68. http://dx.doi.org/10.1016/j.jaci.2007.12.270.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Skowron, F., B. Bensaid, B. Balme, L. Depaepe, J. Kanitakis, A. Nosbaum, D. Maucort-Boulch, et al. "Comparative histological analysis of drug-induced maculopapular exanthema and DRESS." Journal of the European Academy of Dermatology and Venereology 30, no. 12 (July 16, 2016): 2085–90. http://dx.doi.org/10.1111/jdv.13832.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Maculopapular exanthema"

1

William Tong, C. Y. "Exanthemata." In Tutorial Topics in Infection for the Combined Infection Training Programme. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780198801740.003.0047.

Full text
Abstract:
An exanthem (or exanthema) is a widespread skin rash accompanying a disease or fever. It usually occurs in children as part of a common systemic childhood viral infection, but can also occur in adults and can be caused by bacterial infections, toxin or drug reactions. An enanthem (or enanthema) is a rash that occurs in the mucous membrane, typically in the mouth, as the result of the same disease process of an exanthema. Because the presence of a rash is a very striking feature, historically, several of the commonly seen febrile illnesses associated with rash have been recognized and named in numerical order. There are various things to look out for when assessing a patient with exanthema. These can include the type and evolution of the rash, as well as contact, vaccine, drug, sexual, and travel history. ● Type of rash: ■ maculopapular; ■ vesicular; ■ petechial. ● Evolution of the rash: ■ prodrome, if any; ■ date of onset of fever; ■ date of onset of the rash; ■ progression of the rash (e.g. starting location and spread); ■ other associated features (e.g. conjunctivitis, lymphadenopathy, hepatosplenomegaly). ● Contact history: ■ history of contact with anyone with febrile or rash illness; ■ recent local outbreaks, if any; ■ contact with other vulnerable individuals before and after onset of illness (for infection control purposes). ● Vaccine history: ■ recent history of any vaccination; ■ previous vaccination history (particularly MMR and varicella); ■ timing of these vaccines and number of doses. ● Drug history: ■ including antibiotics given for the illness. ● Sexual history: ■ always consider this in any patient. ● Recent travel history: ■ record timing and location; ■ history of insect bites. A good description of the rash can help in narrowing down the possible causes. The commonly seen rashes can be maculopapular, vesicular, or petechial. Maculopapular rash can be further categorized into subtypes. These include: ● morbilliform—a red rash which is measles-like, two to ten mm in diameter, and which merge to form confluent patches.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography